Cargando…
Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell‐free products and human pluripotent stem cell‐derived mesenchymal stem cells
Mesenchymal stem cell therapy (MSCT) for immune and inflammatory diseases continues to be popular based on progressive accumulation of preclinical mechanistic evidence. This has led to further expansion in clinical indications from graft rejection, autoimmune diseases, and osteoarthritis, to inflamm...
Autores principales: | Wang, Li‐Tzu, Liu, Ko‐Jiunn, Sytwu, Huey‐Kang, Yen, Men‐Luh, Yen, B. Linju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380447/ https://www.ncbi.nlm.nih.gov/pubmed/34008922 http://dx.doi.org/10.1002/sctm.21-0021 |
Ejemplares similares
-
Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID‐19
por: Yen, B. Linju, et al.
Publicado: (2020) -
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
por: Chen, Pei-Min, et al.
Publicado: (2011) -
Three-Dimensional Spheroid Culture of Human Mesenchymal Stem Cells: Offering Therapeutic Advantages and In Vitro Glimpses of the In Vivo State
por: Yen, B Linju, et al.
Publicado: (2023) -
Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials
por: Wang, Li-Tzu, et al.
Publicado: (2016) -
HLA-G Expression in Human Mesenchymal Stem Cells (MSCs) Is Related to Unique Methylation Pattern in the Proximal Promoter as well as Gene Body DNA
por: Yen, B. Linju, et al.
Publicado: (2020)